BMY vs FDUS · P/E 17, rev $24.46B vs P/E 8.7, rev $126.4M
Bristol-Myers Squibb Company (BMY) versus Fidus Investment Corp (FDUS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Fidus Investment Corp (FDUS) is a asset management company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FDUS revenue for 2025-12-31 was $126.4M. Net income was $82.4M. Revenue was up 2.6% from 2024-12-31 to 2025-12-31. FDUS currently screens at market cap $712.8M and trailing P/E 8.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FDUS currently screens at market cap $712.8M and trailing P/E 8.7.
Not investment advice. Open the BMY and FDUS stock pages for the full models.
Not investment advice.